Hirsch FR - Search Results

1

PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.

McGowan M, Hoven AS, Lund-Iversen M, Solberg S, Helland Å, Hirsch FR, Brustugun OT. McGowan M, et al. Among authors: hirsch fr. Lung Cancer. 2017 Jan;103:52-57. doi: 10.1016/j.lungcan.2016.11.018. Epub 2016 Nov 28. Lung Cancer. 2017. PMID: 28024696

2

Intracranial metastases in small cell carcinoma of the lung. Prognostic aspects.

Hirsch FR, Paulson OB, Hansen HH, Larsen SO. Hirsch FR, et al. Cancer. 1983 Feb 1;51(3):529-33. doi: 10.1002/1097-0142(19830201)51:3<529::aid-cncr2820510327>3.0.co;2-0. Cancer. 1983. PMID: 6295606

3

Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?

Lassen UN, Hirsch FR, Osterlind K, Bergman B, Dombernowsky P. Lassen UN, et al. Among authors: hirsch fr. Lung Cancer. 1998 Jun;20(3):151-60. doi: 10.1016/s0169-5002(98)00011-7. Lung Cancer. 1998. PMID: 9733049

4

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas.

Hirsch FR, Varella-Garcia M, Franklin WA, Veve R, Chen L, Helfrich B, Zeng C, Baron A, Bunn PA Jr. Hirsch FR, et al. Br J Cancer. 2002 May 6;86(9):1449-56. doi: 10.1038/sj.bjc.6600286. Br J Cancer. 2002. PMID: 11986780 Free PMC article.

5

High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, Gemmill RM, Drabkin HA, Franklin WA. Bremnes RM, et al. Among authors: hirsch fr. J Clin Oncol. 2002 May 15;20(10):2417-28. doi: 10.1200/JCO.2002.08.159. J Clin Oncol. 2002. PMID: 12011119

6

Molecular approaches to lung cancer evaluation.

Niklinski J, Hirsch FR. Niklinski J, et al. Among authors: hirsch fr. Lung Cancer. 2002 Dec;38 Suppl 3:S9-17. doi: 10.1016/s0169-5002(02)00260-x. Lung Cancer. 2002. PMID: 12468138 Review.

7

Chemoprevention of lung cancer: current status and future prospects.

van Zandwijk N, Hirsch FR. van Zandwijk N, et al. Among authors: hirsch fr. Lung Cancer. 2003 Dec;42 Suppl 1:S71-9. doi: 10.1016/s0169-5002(03)00307-6. Lung Cancer. 2003. PMID: 14611918 Review.

8

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A, Tonato M, Franklin WA, Crino L, Bunn PA Jr, Varella-Garcia M. Cappuzzo F, et al. Among authors: hirsch fr. J Natl Cancer Inst. 2005 May 4;97(9):643-55. doi: 10.1093/jnci/dji112. J Natl Cancer Inst. 2005. PMID: 15870435 Clinical Trial.

9

High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.

Kennedy TC, Franklin WA, Prindiville SA, Cook R, Dempsey EC, Keith RL, Hirsch FR, Merrick TA, Shroyer KR, Petty TL, Byers T, Bunn PA Jr, Miller YE. Kennedy TC, et al. Among authors: hirsch fr. Lung Cancer. 2005 Aug;49(2):187-91. doi: 10.1016/j.lungcan.2005.02.009. Epub 2005 Apr 14. Lung Cancer. 2005. PMID: 16022912

10

Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients.

Cappuzzo F, Varella-Garcia M, Shigematsu H, Domenichini I, Bartolini S, Ceresoli GL, Rossi E, Ludovini V, Gregorc V, Toschi L, Franklin WA, Crino L, Gazdar AF, Bunn PA Jr, Hirsch FR. Cappuzzo F, et al. Among authors: hirsch fr. J Clin Oncol. 2005 Aug 1;23(22):5007-18. doi: 10.1200/JCO.2005.09.111. J Clin Oncol. 2005. PMID: 16051952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page